Algocell.ai

Algocell is an AI-powered bioprocess modeling platform that combines traditional bioprocess engineering with machine learning to create Digital Twins. The platform enables users to upload biological and engineering data to calibrate highly accurate models, allowing for the simulation of thousands of in-silico scenarios. This approach is designed to replace costly, time-consuming trial-and-error experimentation with simulated insights, helping companies validate conceptual designs and predict outcomes during both development and manufacturing phases. By leveraging this hybrid modeling approach—which integrates biological mechanistic models with advanced AI—the platform provides a versatile infrastructure that adapts to specific cell line metabolism and equipment constraints.

This technology is primarily targeted at cell-based companies within industries such as foodtech, biotechnology, and pharmaceuticals, particularly those involved in precision fermentation and cultivated food production. By reducing trial-and-error experiments, Algocell helps these organizations accelerate their time-to-market and optimize cell productivity while ensuring consistent production quality. The company, headquartered in Rehovot, Israel, and founded in 2023, focuses on empowering biomanufacturing firms to maximize their process efficiency, increase margins, and achieve seamless transitions from pilot testing to full-scale production.